CN Stock MarketDetailed Quotes

688253 Innovita Biological Technology

Watchlist
  • 42.80
  • +1.43+3.46%
Trading Nov 8 13:47 CST
5.84BMarket Cap17.59P/E (TTM)

Innovita Biological Technology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
87.05%520.82M
88.33%421.06M
109.36%281.61M
7.03%478.02M
-10.34%278.43M
-10.49%223.58M
93.55%134.51M
36.62%446.62M
17.46%310.53M
15.06%249.79M
Operating revenue
87.05%520.82M
88.33%421.06M
109.36%281.61M
7.03%478.02M
-10.34%278.43M
-10.49%223.58M
93.55%134.51M
36.62%446.62M
17.46%310.53M
15.06%249.79M
Total operating cost
43.16%247.2M
42.95%177.7M
26.94%99.56M
-11.34%262.27M
-2.75%172.68M
-9.66%124.31M
47.68%78.43M
46.27%295.83M
20.31%177.55M
24.78%137.6M
Operating cost
25.46%99.2M
18.99%77.42M
0.68%46.33M
-33.74%114.81M
-30.20%79.07M
-26.61%65.07M
92.03%46.02M
127.17%173.28M
89.44%113.29M
91.48%88.66M
Operating tax surcharges
41.14%3.08M
42.50%2.32M
51.12%1.53M
-64.16%3.21M
-65.95%2.18M
-53.13%1.63M
39.11%1.01M
204.74%8.95M
174.76%6.41M
85.00%3.48M
Operating expense
70.22%55.55M
84.07%38.16M
87.14%20.31M
15.72%58.18M
-0.48%32.63M
11.57%20.73M
20.16%10.85M
5.09%50.28M
-1.70%32.79M
-19.81%18.58M
Administration expense
-1.23%32.31M
-7.72%19.33M
10.68%10.82M
0.88%40.92M
20.32%32.71M
26.81%20.95M
37.05%9.77M
12.30%40.56M
-3.34%27.19M
-15.69%16.52M
Financial expense
52.84%-3.93M
44.32%-3.75M
-280.11%-1.41M
83.89%-7.96M
83.55%-8.32M
71.67%-6.73M
-42.92%784.5K
-720.50%-49.42M
-4,697.91%-50.6M
-824.06%-23.74M
-Interest expense (Financial expense)
-43.25%91.28K
-41.49%65.53K
-37.86%36.19K
-51.25%199.59K
-30.91%160.86K
-33.63%112K
-38.28%58.24K
205.82%409.45K
103.10%232.83K
80.77%168.73K
-Interest Income (Financial expense)
27.04%-4.73M
32.38%-3.35M
50.85%-1.34M
-5.41%-7.64M
-36.00%-6.48M
-287.41%-4.95M
-367.20%-2.72M
-259.68%-7.25M
-166.77%-4.76M
-8.14%-1.28M
Research and development
77.28%60.99M
95.07%44.21M
120.09%21.98M
-26.42%53.11M
-29.03%34.4M
-33.56%22.66M
-8.17%9.99M
132.00%72.18M
112.01%48.47M
112.52%34.11M
Credit Impairment Loss
-835.55%-13.06M
-1,066.15%-19.02M
-5,927.37%-19.01M
32.51%-4.52M
60.85%-1.4M
55.50%-1.63M
260.62%326.15K
-2,026.49%-6.69M
-10,309.50%-3.57M
-11,307.40%-3.66M
Asset Impairment Loss
92.21%-2.04M
91.51%-2.04M
89.02%-378.93K
-6,695.09%-45.24M
-5,618.72%-26.23M
-9,305.58%-24.07M
-2,748.09%-3.45M
30.65%-665.79K
13.81%-458.74K
-144.08%-255.92K
Other net revenue
Fair value change income
2.06%4.68M
5.54%4.48M
148.15%4.86M
311.13%9.15M
1,565.53%4.59M
2,123.03%4.25M
579.85%1.96M
151.22%2.23M
-53.62%275.31K
-56.32%191K
Invest income
50.17%18.12M
80.16%11.59M
26.62%4.85M
248.36%16.93M
1,401.24%12.07M
305.30%6.43M
730.62%3.83M
208.66%4.86M
-46.58%803.89K
25.12%1.59M
-Including: Investment income associates
----
42.73%-936.32K
---1.06M
-0.24%-1.06M
----
---1.63M
----
---1.06M
----
----
Asset deal income
--221.68
---806.39
--22.09
-82.92%2.19K
----
----
----
--12.83K
--12.83K
--12.83K
Other revenue
-74.23%1.81M
-79.59%1.32M
-74.65%869.75K
-54.72%7.98M
-49.28%7.02M
-50.69%6.47M
-72.91%3.43M
32.69%17.63M
423.51%13.83M
428.63%13.12M
Operating profit
178.13%283.13M
164.23%239.69M
178.66%173.25M
18.97%200.05M
-29.25%101.8M
-26.36%90.71M
109.05%62.17M
20.30%168.16M
18.87%143.88M
11.04%123.18M
Add:Non operating Income
129.36%203.36K
375.08%214.83K
712.38%254.59K
97.36%290.19K
-4.78%88.66K
-47.82%45.22K
29.05%31.34K
189.73%147.04K
414.87%93.11K
564.07%86.66K
Less:Non operating expense
-91.64%139.9K
-95.06%62.18K
142,003.66%239.29K
-47.84%1.98M
-32.45%1.67M
-48.03%1.26M
-99.96%168.39
86.80%3.8M
140.70%2.48M
135.47%2.42M
Total profit
182.59%283.19M
167.99%239.84M
178.54%173.26M
20.58%198.36M
-29.18%100.21M
-25.94%89.5M
112.11%62.2M
19.38%164.51M
17.89%141.5M
9.94%120.84M
Less:Income tax cost
182.18%38.58M
177.86%33.58M
224.14%27.18M
76.60%24.41M
-0.97%13.67M
-1.52%12.09M
182.14%8.38M
-21.66%13.82M
-9.28%13.81M
-15.31%12.27M
Net profit
182.65%244.61M
166.45%206.26M
171.44%146.09M
15.44%173.95M
-32.23%86.54M
-28.70%77.41M
104.21%53.82M
25.40%150.68M
21.83%127.69M
13.78%108.57M
Net profit from continuing operation
182.65%244.61M
166.45%206.26M
171.44%146.09M
15.44%173.95M
-32.23%86.54M
-28.70%77.41M
104.21%53.82M
25.40%150.68M
21.83%127.69M
13.78%108.57M
Less:Minority Profit
----
----
----
----
----
----
----
----
----
99.64%-335.53
Net profit of parent company owners
182.65%244.61M
166.45%206.26M
171.44%146.09M
15.44%173.95M
-32.23%86.54M
-28.70%77.41M
104.21%53.82M
25.31%150.68M
21.73%127.69M
13.67%108.57M
Earning per share
Basic earning per share
181.25%1.8
166.67%1.52
167.50%1.07
3.23%1.28
-35.35%0.64
-46.23%0.57
53.85%0.4
5.08%1.24
-3.88%0.99
12.77%1.06
Diluted earning per share
181.25%1.8
164.91%1.51
167.50%1.07
3.23%1.28
-35.35%0.64
-46.23%0.57
53.85%0.4
5.08%1.24
-3.88%0.99
12.77%1.06
Other composite income
-367.59%-3.49M
-300.37%-2.89M
63.23K
-1.02M
1.3M
1.44M
Other composite income of parent company owners
-367.59%-3.49M
-300.37%-2.89M
--63.23K
---1.02M
--1.3M
--1.44M
----
----
----
----
Total composite income
174.48%241.11M
157.92%203.38M
171.56%146.15M
14.76%172.92M
-31.21%87.84M
-27.37%78.85M
104.21%53.82M
25.40%150.68M
21.83%127.69M
13.78%108.57M
Total composite income of parent company owners
174.48%241.11M
157.92%203.38M
171.56%146.15M
14.76%172.92M
-31.21%87.84M
-27.37%78.85M
104.21%53.82M
25.31%150.68M
21.73%127.69M
13.67%108.57M
Total composite income of minority owners
----
----
----
----
----
----
----
----
----
99.64%-335.53
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
--
--
--
Auditor
--
--
--
Daxin Certified Public Accountants (Special General Partnership)
--
--
--
Daxin Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Total operating revenue 87.05%520.82M88.33%421.06M109.36%281.61M7.03%478.02M-10.34%278.43M-10.49%223.58M93.55%134.51M36.62%446.62M17.46%310.53M15.06%249.79M
Operating revenue 87.05%520.82M88.33%421.06M109.36%281.61M7.03%478.02M-10.34%278.43M-10.49%223.58M93.55%134.51M36.62%446.62M17.46%310.53M15.06%249.79M
Total operating cost 43.16%247.2M42.95%177.7M26.94%99.56M-11.34%262.27M-2.75%172.68M-9.66%124.31M47.68%78.43M46.27%295.83M20.31%177.55M24.78%137.6M
Operating cost 25.46%99.2M18.99%77.42M0.68%46.33M-33.74%114.81M-30.20%79.07M-26.61%65.07M92.03%46.02M127.17%173.28M89.44%113.29M91.48%88.66M
Operating tax surcharges 41.14%3.08M42.50%2.32M51.12%1.53M-64.16%3.21M-65.95%2.18M-53.13%1.63M39.11%1.01M204.74%8.95M174.76%6.41M85.00%3.48M
Operating expense 70.22%55.55M84.07%38.16M87.14%20.31M15.72%58.18M-0.48%32.63M11.57%20.73M20.16%10.85M5.09%50.28M-1.70%32.79M-19.81%18.58M
Administration expense -1.23%32.31M-7.72%19.33M10.68%10.82M0.88%40.92M20.32%32.71M26.81%20.95M37.05%9.77M12.30%40.56M-3.34%27.19M-15.69%16.52M
Financial expense 52.84%-3.93M44.32%-3.75M-280.11%-1.41M83.89%-7.96M83.55%-8.32M71.67%-6.73M-42.92%784.5K-720.50%-49.42M-4,697.91%-50.6M-824.06%-23.74M
-Interest expense (Financial expense) -43.25%91.28K-41.49%65.53K-37.86%36.19K-51.25%199.59K-30.91%160.86K-33.63%112K-38.28%58.24K205.82%409.45K103.10%232.83K80.77%168.73K
-Interest Income (Financial expense) 27.04%-4.73M32.38%-3.35M50.85%-1.34M-5.41%-7.64M-36.00%-6.48M-287.41%-4.95M-367.20%-2.72M-259.68%-7.25M-166.77%-4.76M-8.14%-1.28M
Research and development 77.28%60.99M95.07%44.21M120.09%21.98M-26.42%53.11M-29.03%34.4M-33.56%22.66M-8.17%9.99M132.00%72.18M112.01%48.47M112.52%34.11M
Credit Impairment Loss -835.55%-13.06M-1,066.15%-19.02M-5,927.37%-19.01M32.51%-4.52M60.85%-1.4M55.50%-1.63M260.62%326.15K-2,026.49%-6.69M-10,309.50%-3.57M-11,307.40%-3.66M
Asset Impairment Loss 92.21%-2.04M91.51%-2.04M89.02%-378.93K-6,695.09%-45.24M-5,618.72%-26.23M-9,305.58%-24.07M-2,748.09%-3.45M30.65%-665.79K13.81%-458.74K-144.08%-255.92K
Other net revenue
Fair value change income 2.06%4.68M5.54%4.48M148.15%4.86M311.13%9.15M1,565.53%4.59M2,123.03%4.25M579.85%1.96M151.22%2.23M-53.62%275.31K-56.32%191K
Invest income 50.17%18.12M80.16%11.59M26.62%4.85M248.36%16.93M1,401.24%12.07M305.30%6.43M730.62%3.83M208.66%4.86M-46.58%803.89K25.12%1.59M
-Including: Investment income associates ----42.73%-936.32K---1.06M-0.24%-1.06M-------1.63M-------1.06M--------
Asset deal income --221.68---806.39--22.09-82.92%2.19K--------------12.83K--12.83K--12.83K
Other revenue -74.23%1.81M-79.59%1.32M-74.65%869.75K-54.72%7.98M-49.28%7.02M-50.69%6.47M-72.91%3.43M32.69%17.63M423.51%13.83M428.63%13.12M
Operating profit 178.13%283.13M164.23%239.69M178.66%173.25M18.97%200.05M-29.25%101.8M-26.36%90.71M109.05%62.17M20.30%168.16M18.87%143.88M11.04%123.18M
Add:Non operating Income 129.36%203.36K375.08%214.83K712.38%254.59K97.36%290.19K-4.78%88.66K-47.82%45.22K29.05%31.34K189.73%147.04K414.87%93.11K564.07%86.66K
Less:Non operating expense -91.64%139.9K-95.06%62.18K142,003.66%239.29K-47.84%1.98M-32.45%1.67M-48.03%1.26M-99.96%168.3986.80%3.8M140.70%2.48M135.47%2.42M
Total profit 182.59%283.19M167.99%239.84M178.54%173.26M20.58%198.36M-29.18%100.21M-25.94%89.5M112.11%62.2M19.38%164.51M17.89%141.5M9.94%120.84M
Less:Income tax cost 182.18%38.58M177.86%33.58M224.14%27.18M76.60%24.41M-0.97%13.67M-1.52%12.09M182.14%8.38M-21.66%13.82M-9.28%13.81M-15.31%12.27M
Net profit 182.65%244.61M166.45%206.26M171.44%146.09M15.44%173.95M-32.23%86.54M-28.70%77.41M104.21%53.82M25.40%150.68M21.83%127.69M13.78%108.57M
Net profit from continuing operation 182.65%244.61M166.45%206.26M171.44%146.09M15.44%173.95M-32.23%86.54M-28.70%77.41M104.21%53.82M25.40%150.68M21.83%127.69M13.78%108.57M
Less:Minority Profit ------------------------------------99.64%-335.53
Net profit of parent company owners 182.65%244.61M166.45%206.26M171.44%146.09M15.44%173.95M-32.23%86.54M-28.70%77.41M104.21%53.82M25.31%150.68M21.73%127.69M13.67%108.57M
Earning per share
Basic earning per share 181.25%1.8166.67%1.52167.50%1.073.23%1.28-35.35%0.64-46.23%0.5753.85%0.45.08%1.24-3.88%0.9912.77%1.06
Diluted earning per share 181.25%1.8164.91%1.51167.50%1.073.23%1.28-35.35%0.64-46.23%0.5753.85%0.45.08%1.24-3.88%0.9912.77%1.06
Other composite income -367.59%-3.49M-300.37%-2.89M63.23K-1.02M1.3M1.44M
Other composite income of parent company owners -367.59%-3.49M-300.37%-2.89M--63.23K---1.02M--1.3M--1.44M----------------
Total composite income 174.48%241.11M157.92%203.38M171.56%146.15M14.76%172.92M-31.21%87.84M-27.37%78.85M104.21%53.82M25.40%150.68M21.83%127.69M13.78%108.57M
Total composite income of parent company owners 174.48%241.11M157.92%203.38M171.56%146.15M14.76%172.92M-31.21%87.84M-27.37%78.85M104.21%53.82M25.31%150.68M21.73%127.69M13.67%108.57M
Total composite income of minority owners ------------------------------------99.64%-335.53
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------------
Auditor ------Daxin Certified Public Accountants (Special General Partnership)------Daxin Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data